InvestorsHub Logo

DewDiligence

11/17/16 11:11 AM

#206161 RE: DewDiligence #206133

INCY +5% on GILD’s lukewarm—(at best)—Momelotinib data (#msg-126609986). Jakafi looks pretty good by comparison.